aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinurie, paroxysmale - immunosuppressiva - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
xenical
cheplapharm arzneimittel gmbh - orlistat - zwaarlijvigheid - preparaten tegen obesitas, excl. dieetproducten - xenical is geïndiceerd in combinatie met een mild hypocalorisch dieet voor de behandeling van obese patiënten met een body mass index (bmi) groter of gelijk aan 30 kg / m2, of patiënten met overgewicht (bmi> 28 kg / m2) met bijbehorende risicofactoren. de behandeling met orlistat moet worden gestaakt na 12 weken bij patiënten die niet in staat zijn geweest om de verliezen van ten minste 5% van het lichaamsgewicht, zoals dat werd gemeten bij het begin van de therapie.
eucreas
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).
zomarist
novartis europharm limited - vildagliptin, metformine hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
glimepiride mylan 1 mg, tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - glimepiride - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide rood (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride
glimepiride mylan 2 mg, tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - glimepiride - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride
glimepiride mylan 3 mg, tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - glimepiride - tablet - cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; ijzeroxide geel (e 172) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride
glimepiride mylan 4 mg, tabletten
mylan b.v. dieselweg 25 3752 lb bunschoten - glimepiride - tablet - cellulose, microkristallijn (e 460) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; povidon (e 1201), cellulose, microkristallijn (e 460) ; indigokarmijn aluminiumlak (e 132) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; povidon (e 1201), - glimepiride
metformine hcl cf 850 mg, omhulde tabletten
centrafarm b.v. - metforminehydrochloride; - omhulde tablet - metformin